The independent platform for news, articles and advice for professionals in laboratory medicine

MRC innovation funding to tackle hard-to-treat cancers

The Medical Research Council (MRC) has announced a new £2 million investment supporting researchers to understand and treat cancers with exceptionally poor survival rates, including of the brain, lung and oesophagus. Four research innovation teams will each receive £500,000 to work across disciplines on high-risk, high-reward projects towards improving outcomes of hard-to-treat cancers.

The projects were selected following a two-day ‘sandpit’ event designed to promote new conversations and create teams of researchers across scientific disciplines from clinical, biomedical, engineering, physical and data sciences. The teams co-developed innovative ideas and solutions to advance cancer research including for prevention, diagnosis and treatment.

One of the successful projects, to be led by Tim Witney at Kings College London, will take forward research on using artificial intelligence to read lung scans and more accurately predict whether a cancer is resistant to treatment. This data will then be used to create targeted drugs that selectively kill treatment-resistant cancer cells.

Another project, this time led by Sara Valpione, The University of Manchester and The Christie NHS Foundation Trust, will explore ways to optimise engineered nanoparticle therapeutics for oesophageal cancer. Researchers hope to target cells that hinder effectiveness of medicines that boost the immune system against cancer.

Dr Megan Dowie, MRC’s Head of Molecular and Cellular Medicine, said: “We look forward to supporting the teams towards achieving real-world impacts, both in a clinical setting and the real hope they may ultimately be able to offer to those suffering from some of the most challenging cancer diagnoses.

“We were inspired by the success of the sandpit event. The many new interdisciplinary connections formed over the two-days will have a lasting legacy of future collaboration of life and physical sciences researchers. This will help achieve the step change we need to address hard-to-treat cancers with potential for translation to other types of cancer too.”

Additionally, a team led by Philippe Wilson at Nottingham Trent University has received a £50,000 pump-priming grant to develop a proof-of-concept lateral flow test for the early detection of brain tumour recurrence, suitable for future patient self-administration. The funding will allow these teams to further the ideas developed at the sandpit for possible future funding.

 

Upcoming Events

BSI Congress

ICC Belfast, BT1 3WH
4-7 December

Digital Pathology & AI Congress: Europe

The Intercontinental London Hotel, The O2, London SE10 0TW
7-8 December

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
2 May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

BSI Congress

ICC Belfast, BT1 3WH
4-7 December

Digital Pathology & AI Congress: Europe

The Intercontinental London Hotel, The O2, London SE10 0TW
7-8 December

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
2 May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2023 Step Communications Ltd. Registered in England. Registration Number 3893025